Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
JHMH Stock Summary
In the News
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.
Healthcare: A Wide Choice Of Large And Well-Established Companies
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.
Cracking Open Factors: Beyond the Style Box
While 2020 may feel like a “this time it's different” year, the reality is the core underpinnings of what makes for a winning portfolio haven't changed: controlling expenses, managing your taxes, and most importantly, having the right exposures for the current market regime. But with wild swings in both sectors and factors, how do you [.
5 Reasons To Consider Investing In Health Care
Health care is a play on demographics and an aging population. The pandemic sheds light on the importance of health care to national security.
The Reopening Killed The V-Shaped Recovery
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
COVID-19: Healthcare Is More Protected
The most negative impacts that we are seeing are among the consumer-facing healthcare businesses with services that are easily deferrable. Among the most resili
Will These Tech Stock Valuations Last?
Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
Investing In The Prospect Of Drug Pricing Reforms
The Trump Administration is considering reforms in the payment for prescription drugs covered under Medicare Part B. The changes include ones that could be acco
Why We Like Healthcare Stocks In 2020
In a year-end poll of our Fundamental Active Equity investors, two themes stood out: The U.S. election is seen as a key market driver, and healthcare is among o